, pub-5167539840471953, DIRECT, f08c47fec0942fa0

In order to avoid answering harsh questions about the shady nature of vaccination sales, Albert Bourla canceled his scheduled appearance before European Legislature’s special committee on COVID-19.

The decision was made after a report on an audit into the European Union’s vaccine procurement strategy was released earlier this month, raising new questions about communications between Bourla as well as European Commission President Ursula von der Leyen prior to the awarding of a multibillion-euro vaccine contract.

On October 10th, the panel invited the CEO of a U.S. pharmaceutical corporation that supplies the majority of the COVID-19 vaccinations used in the European Union. In order to better prepare for future pandemics, the committee is holding meetings with key individuals engaged in the EU’s vaccine procurement. The CEO of Moderna as well as high-ranking officials representing AstraZeneca and Sanofi have all spoken before the committee, but this time Pfizer’s CEO ran for the hills and was a NO SHOW. I wonder if you or I did that, would the judge issue a bench warrant for our arrest?

We need your help to continue to post news that matters...You can support our efforts by buying us a coffee... It’s quick, secure, and easy.